Home > Healthcare > Microarray Scanners Market > Table of Contents

Microarray Scanners Market, By Product Type (Fluorescence, Charge-coupled Devices, Colorimetric Microarray Scanners), Application (Gene Expression, Protein Microarray, Drug Discovery, Genotyping & SNP Analysis), End-use – Global Forecast (2024 – 2032)

  • Report ID: GMI9677
  • Published Date: May 2024
  • Report Format: PDF

Report Content

Chapter 1   Methodology & Scope

1.1    Market scope & definitions

1.2    Research design

1.2.1    Research approach

1.2.2    Data collection methods

1.3    Base estimates & calculations

1.3.1    Base year calculation

1.3.2    Key trends for market estimation

1.4    Forecast model

1.5    Primary research and validation

1.5.1    Primary sources

1.5.2    Data mining sources

Chapter 2   Executive Summary

2.1    Industry 3600 synopsis

Chapter 3   Industry Insights

3.1    Industry ecosystem analysis

3.2    Industry impact forces

3.2.1    Growth drivers

3.2.1.1   Advancements in genomics and proteomics research

3.2.1.2   Rising prevalence of chronic diseases

3.2.1.3   Growing technological advancements

3.2.2    Industry pitfalls & challenges

3.2.2.1   High cost associated with microarray scanners

3.2.2.2   Stringent regulatory requirements

3.3    Growth potential analysis

3.4    Technological landscape

3.5    Regulatory landscape

3.6    Porter's analysis

3.7    PESTEL analysis

Chapter 4   Competitive Landscape, 2023

4.1    Introduction

4.2    Company market share analysis

4.3    Competitive positioning matrix

4.4    Strategy outlook matrix

Chapter 5   Market Estimates and Forecast, By Product Type, 2021 – 2032 ($ Mn)

5.1    Key trends

5.2    Fluorescence microarray scanners

5.3    Charge-coupled devices microarray scanners

5.4    Colorimetric microarray scanners

5.5    Other types

Chapter 6   Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)

6.1    Key trends

6.2    Gene expression analysis

6.3    Protein microarrays

6.4    Drug discovery

6.5    Genotyping and SNP analysis

6.6    Other applications

Chapter 7   Market Estimates and Forecast, By End-Use, 2021 – 2032 ($ Mn)

7.1    Key trends

7.2    Hospitals and clinics

7.3    Pharmaceutical and biotechnology companies

7.4    Diagnostic laboratories

7.5    Academic and research institutes

7.6    Other end-users

Chapter 8   Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)

8.1    Key trends

8.2    North America

8.2.1    U.S.

8.2.2    Canada

8.3    Europe

8.3.1    Germany

8.3.2    UK

8.3.3    France

8.3.4    Spain

8.3.5    Italy

8.3.6    Netherlands

8.3.7    Rest of Europe

8.4    Asia Pacific

8.4.1    Japan

8.4.2    China

8.4.3    India

8.4.4    Australia

8.4.5    South Korea

8.4.6    Rest of Asia Pacific

8.5    Latin America

8.5.1    Brazil

8.5.2    Mexico

8.5.3    Argentina

8.5.4    Rest of Latin America

8.6    Middle East and Africa

8.6.1    Saudi Arabia

8.6.2    South Africa

8.6.3    UAE

8.6.4    Rest of Middle East and Africa

Chapter 9   Company Profiles

9.1    Agilent Technologies, Inc.

9.2    Arrayit Corporation

9.3    Aushon BioSystems

9.4    Bio-Rad Laboratories, Inc.

9.5    Danaher Corporation

9.6    F. Hoffmann-La Roche Ltd.

9.7    Hitachi High-Tech Corporation

9.8    Illumina, Inc.

9.9    LI-COR Biosciences

9.10    Microarrays, Inc.

9.11    Oxford Gene Technology

9.12    PerkinElmer, Inc.

9.13    SciGene Corporation

9.14    Tecan Group Ltd.

9.15    Thermo Fisher Scientific, Inc.
 

Authors: Mariam Faizullabhoy, Gauri Wani

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 15
  • Tables & Figures: 225
  • Countries covered: 23
  • Pages: 140
 Download Free Sample